協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/06/11 | 1,055 | 1,104 | 1,048 | 1,094 | +34 | +3.2% | 2,834,000 |
| 2013/06/10 | 1,057 | 1,072 | 1,034 | 1,060 | +32 | +3.1% | 2,049,000 |
| 2013/06/07 | 1,018 | 1,041 | 1,005 | 1,028 | -13 | -1.2% | 2,293,000 |
| 2013/06/06 | 1,049 | 1,074 | 1,033 | 1,041 | -9 | -0.9% | 2,441,000 |
| 2013/06/05 | 1,066 | 1,110 | 1,050 | 1,050 | -40 | -3.7% | 2,197,000 |
| 2013/06/04 | 1,079 | 1,097 | 1,067 | 1,090 | +9 | +0.8% | 1,859,000 |
| 2013/06/03 | 1,110 | 1,141 | 1,079 | 1,081 | -59 | -5.2% | 2,961,000 |
| 2013/05/31 | 1,082 | 1,140 | 1,081 | 1,140 | +81 | +7.6% | 5,064,000 |
| 2013/05/30 | 1,085 | 1,094 | 1,051 | 1,059 | -48 | -4.3% | 3,485,000 |
| 2013/05/29 | 1,091 | 1,118 | 1,086 | 1,107 | +23 | +2.1% | 3,144,000 |
| 2013/05/28 | 1,088 | 1,113 | 1,080 | 1,084 | -29 | -2.6% | 2,509,000 |
| 2013/05/27 | 1,087 | 1,129 | 1,078 | 1,113 | -13 | -1.2% | 2,172,000 |
| 2013/05/24 | 1,132 | 1,143 | 1,061 | 1,126 | -6 | -0.5% | 2,810,000 |
| 2013/05/23 | 1,228 | 1,246 | 1,131 | 1,132 | -95 | -7.7% | 2,737,000 |
| 2013/05/22 | 1,227 | 1,232 | 1,218 | 1,227 | ±0 | ±0% | 1,197,000 |
| 2013/05/21 | 1,218 | 1,227 | 1,209 | 1,227 | -1 | -0.1% | 753,000 |
| 2013/05/20 | 1,226 | 1,237 | 1,221 | 1,228 | +2 | +0.2% | 833,000 |
| 2013/05/17 | 1,226 | 1,229 | 1,208 | 1,226 | ±0 | ±0% | 1,311,000 |
| 2013/05/16 | 1,246 | 1,250 | 1,214 | 1,226 | -26 | -2.1% | 1,569,000 |
| 2013/05/15 | 1,248 | 1,256 | 1,242 | 1,252 | +17 | +1.4% | 1,099,000 |
| 2013/05/14 | 1,247 | 1,247 | 1,235 | 1,235 | -7 | -0.6% | 876,000 |
| 2013/05/13 | 1,250 | 1,250 | 1,230 | 1,242 | +5 | +0.4% | 1,211,000 |
| 2013/05/10 | 1,242 | 1,250 | 1,228 | 1,237 | +28 | +2.3% | 1,590,000 |
| 2013/05/09 | 1,241 | 1,249 | 1,207 | 1,209 | -26 | -2.1% | 894,000 |
| 2013/05/08 | 1,220 | 1,250 | 1,214 | 1,235 | +23 | +1.9% | 1,791,000 |
| 2013/05/07 | 1,186 | 1,213 | 1,180 | 1,212 | +53 | +4.6% | 1,613,000 |
| 2013/05/02 | 1,171 | 1,172 | 1,153 | 1,159 | -11 | -0.9% | 895,000 |
| 2013/05/01 | 1,174 | 1,195 | 1,148 | 1,170 | -25 | -2.1% | 1,237,000 |
| 2013/04/30 | 1,198 | 1,205 | 1,183 | 1,195 | -5 | -0.4% | 1,727,000 |
| 2013/04/26 | 1,205 | 1,213 | 1,192 | 1,200 | +3 | +0.3% | 1,281,000 |
| 2013/04/25 | 1,198 | 1,203 | 1,183 | 1,197 | +7 | +0.6% | 1,839,000 |
| 2013/04/24 | 1,201 | 1,204 | 1,162 | 1,190 | -9 | -0.8% | 2,496,000 |
| 2013/04/23 | 1,196 | 1,200 | 1,192 | 1,199 | +2 | +0.2% | 881,000 |
| 2013/04/22 | 1,185 | 1,206 | 1,184 | 1,197 | +23 | +2% | 1,350,000 |
| 2013/04/19 | 1,165 | 1,178 | 1,157 | 1,174 | +15 | +1.3% | 1,089,000 |
| 2013/04/18 | 1,169 | 1,170 | 1,151 | 1,159 | -9 | -0.8% | 1,172,000 |
| 2013/04/17 | 1,154 | 1,168 | 1,146 | 1,168 | +13 | +1.1% | 1,785,000 |
| 2013/04/16 | 1,125 | 1,160 | 1,120 | 1,155 | +13 | +1.1% | 1,193,000 |
| 2013/04/15 | 1,145 | 1,155 | 1,136 | 1,142 | -3 | -0.3% | 1,204,000 |
| 2013/04/12 | 1,158 | 1,162 | 1,138 | 1,145 | +3 | +0.3% | 2,757,000 |
| 2013/04/11 | 1,153 | 1,168 | 1,132 | 1,142 | -11 | -1% | 2,155,000 |
| 2013/04/10 | 1,130 | 1,163 | 1,127 | 1,153 | +27 | +2.4% | 2,217,000 |
| 2013/04/09 | 1,122 | 1,127 | 1,108 | 1,126 | -2 | -0.2% | 1,844,000 |
| 2013/04/08 | 1,122 | 1,135 | 1,110 | 1,128 | +25 | +2.3% | 1,307,000 |
| 2013/04/05 | 1,130 | 1,138 | 1,099 | 1,103 | -1 | -0.1% | 2,025,000 |
| 2013/04/04 | 1,054 | 1,105 | 1,042 | 1,104 | +39 | +3.7% | 2,536,000 |
| 2013/04/03 | 1,042 | 1,065 | 1,035 | 1,065 | +31 | +3% | 1,231,000 |
| 2013/04/02 | 1,050 | 1,050 | 1,006 | 1,034 | -24 | -2.3% | 1,474,000 |
| 2013/04/01 | 1,080 | 1,085 | 1,056 | 1,058 | -16 | -1.5% | 2,171,000 |
| 2013/03/29 | 1,071 | 1,079 | 1,066 | 1,074 | +10 | +0.9% | 1,263,000 |
2951～
3000
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 251,300円 | -3.5% | -11.3% | 2.39% | 23.08倍 | 1.55倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 140,200円 | +0.9% | +380.2% | 5.56% | 19.31倍 | 1.66倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 250,600円 | +20.9% | +10.6% | 2.63% | 11.85倍 | 1.57倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 413,000円 | +0.1% | -3.4% | 3.87% | 28.08倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 158,400円 | +0.6% | +43.3% | 5.05% | 11.11倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
